Cross-Sectional Survey of Factors Contributing to COVID-19 Testing Hesitancy Among US Adults at Risk of Severe Outcomes from COVID-19.
Saved in:
| Title: | Cross-Sectional Survey of Factors Contributing to COVID-19 Testing Hesitancy Among US Adults at Risk of Severe Outcomes from COVID-19. |
|---|---|
| Authors: | Assaf AR; Global Medical Patient Impact Assessment, Worldwide Medical and Safety, Pfizer Inc, Groton, CT, USA.; Brown University School of Public Health, Providence, RI, USA., Sidhu GS; US Medical Affairs, Pfizer Inc, 537 Alandele Ave, Los Angeles, CA, 90036, USA. gurinder.sidhu@pfizer.com., Soni A; Program in Digital Medicine, University of Massachusetts, North Worcester, MA, USA., Cappelleri JC; Biostatistics, Pfizer Inc, Groton, CT, USA., Draica F; US Medical Affairs, Pfizer Inc, New York, NY, USA., Herbert C; Program in Digital Medicine, University of Massachusetts, North Worcester, MA, USA., Arham I; US Medical Affairs, Pfizer Inc, New York, NY, USA., Bader M; Global Medical Patient Impact Assessment, Worldwide Medical and Safety, Pfizer Inc, New York, NY, USA., Jimenez C; Global Medical Grants/Institute of Translational Equitable Medicine, Worldwide Medical and Safety, Pfizer Inc, New York, NY, USA., Bois M; US Medical Affairs, Pfizer Inc, New York, NY, USA., Silvester E; Strategy Consulting, IQVIA, New York, NY, USA., Meservey J; Strategy Consulting, IQVIA, Boston, MA, USA., Eng V; Strategy Consulting, IQVIA, New York, NY, USA., Nelson M; Strategy Consulting, IQVIA, Boston, MA, USA., Cai Y; Advanced Analytics, IQVIA, Wayne, PA, USA., Nangarlia A; Strategy Consulting, IQVIA, Boston, MA, USA., Tian Z; Advanced Analytics, IQVIA, Wayne, PA, USA., Liu Y; Advanced Analytics, IQVIA, Wayne, PA, USA., Watt S; Global Medical Patient Impact Assessment, Worldwide Medical and Safety, Pfizer Inc, New York, NY, USA. |
| Source: | Infectious diseases and therapy [Infect Dis Ther] 2024 Jul; Vol. 13 (7), pp. 1683-1701. Date of Electronic Publication: 2024 Jun 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Adis Country of Publication: New Zealand NLM ID: 101634499 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2193-8229 (Print) Linking ISSN: 21936382 NLM ISO Abbreviation: Infect Dis Ther Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2193-8229 |
|---|---|
| DOI: | 10.1007/s40121-024-01001-5 |
